Literature DB >> 23252872

Detection of HEY1-NCOA2 fusion by fluorescence in-situ hybridization in formalin-fixed paraffin-embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcoma.

Robert Nakayama1, Yasuhiro Miura, Jiro Ogino, Michiro Susa, Itsuo Watanabe, Keisuke Horiuchi, Ukei Anazawa, Yoshiaki Toyama, Hideo Morioka, Makio Mukai, Tadashi Hasegawa.   

Abstract

Mesenchymal chondrosarcoma (MC) is an extremely rare subtype of chondrosarcoma. A tumor specific fusion gene, HEY1-NCOA2 fusion, was recently identified in this tumor. The finding raises the possibility that the diagnosis of MC can be improved by examining the fusion gene. In the present study, we aimed to evaluate the efficacy of fluorescence in situ hybridization (FISH) in detecting HEY1-NCOA2 fusion for the diagnosis of MC. Specimens from 10 patients diagnosed with MC were used for the study. Dual-color FISH was performed using two different probes that specifically hybridize to HEY1 and NCOA2, respectively. Fusion signals were identified in all but two specimens, in which no signal was detected, presumably because of inadequate sample preparation. In accordance with results of a previous study, FISH analysis was highly sensitive in detecting HEY1-NCOA2 fusion in adequately prepared MC samples. The current study adds further support for the use of HEY1-NCOA2 fusion as a valid diagnostic marker for MC.
© 2012 The Authors. Pathology International © 2012 Japanese Society of Pathology and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23252872     DOI: 10.1111/pin.12022

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  16 in total

Review 1.  Small round blue cell tumors of the sinonasal tract: a differential diagnosis approach.

Authors:  Lester Dr Thompson
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

2.  Importance of endothelial Hey1 expression for thoracic great vessel development and its distal enhancer for Notch-dependent endothelial transcription.

Authors:  Yusuke Watanabe; Daiki Seya; Dai Ihara; Shuhei Ishii; Taiki Uemoto; Atsushi Kubo; Yuji Arai; Yoshie Isomoto; Atsushi Nakano; Takaya Abe; Mayo Shigeta; Teruhisa Kawamura; Yoshihiko Saito; Toshihiko Ogura; Osamu Nakagawa
Journal:  J Biol Chem       Date:  2020-10-16       Impact factor: 5.157

Review 3.  Bone- and cartilage-forming tumors and ewing sarcoma: an update with a gnathic emphasis.

Authors:  Brian D Stewart; John D Reith; Jacquelyn A Knapik; Angela C Chi
Journal:  Head Neck Pathol       Date:  2014-11-20

4.  Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors.

Authors:  Amy L Sherborne; Vincent Lavergne; Katharine Yu; Leah Lee; Philip R Davidson; Tali Mazor; Ivan V Smirnoff; Andrew E Horvai; Mignon Loh; Steven G DuBois; Robert E Goldsby; Joseph P Neglia; Sue Hammond; Leslie L Robison; Rosanna Wustrack; Joseph F Costello; Alice O Nakamura; Kevin M Shannon; Smita Bhatia; Jean L Nakamura
Journal:  Clin Cancer Res       Date:  2016-09-28       Impact factor: 12.531

Review 5.  Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology.

Authors:  Marc El Beaino; Jason Roszik; John A Livingston; Wei-Lien Wang; Alexander J Lazar; Behrang Amini; Vivek Subbiah; Valerae Lewis; Anthony P Conley
Journal:  Curr Oncol Rep       Date:  2018-03-26       Impact factor: 5.075

Review 6.  Interstitial Deletions Generating Fusion Genes.

Authors:  Ioannis Panagopoulos; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2021 May-Jun       Impact factor: 4.069

7.  Mesenchymal Chondrosarcoma in Children and Young Adults: A Single Institution Retrospective Review.

Authors:  Michael W Bishop; Jessica M Somerville; Armita Bahrami; Sue C Kaste; Rodrigo B Interiano; Jianrong Wu; Shenghua Mao; Frederick A Boop; Regan F Williams; Alberto S Pappo; Sandeep Samant
Journal:  Sarcoma       Date:  2015-06-03

8.  Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Bodil Bjerkehagen; Kjetil Boye; Sverre Heim
Journal:  Oncol Rep       Date:  2014-05-15       Impact factor: 3.906

9.  Diagnostic use of fluorescence in situ hybridization in expert review in a phase 2 study of trabectedin monotherapy in patients with advanced, translocation-related sarcoma.

Authors:  Shintaro Sugita; Hiroko Asanuma; Tadashi Hasegawa
Journal:  Diagn Pathol       Date:  2016-04-12       Impact factor: 2.644

10.  Mesenchymal chondrosarcoma: imaging features and clinical findings.

Authors:  Soleen Ghafoor; Meera R Hameed; William D Tap; Sinchun Hwang
Journal:  Skeletal Radiol       Date:  2020-07-30       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.